Fertility conversations happen early. Dignity lasts throughout.
Ovarian, uterine, cervical and related cancers — operated by Dr. Patel alongside gynae-oncology colleagues. Staged properly, cytoreduced thoroughly, with the whole person kept larger than the diagnosis.
What are gynaecologic cancers?
They announce themselves in whispers — bleeding after menopause, bleeding between periods, bloating that outlasts a fortnight, pelvic pain that stays. None of these are embarrassing; all of them are checkable.
Surgical staging is the spine of treatment: precise exploration, lymph-node assessment, and for ovarian cancer optimal cytoreduction — where leaving no visible disease behind is what moves survival statistics.
This department operates alongside dedicated gynae-oncology colleagues — a deliberate pairing, because these operations reward both specialties’ hands, and women deserve nothing less than the combined bench strength.
● Fertility-preserving surgery exists for selected early disease — the conversation happens before treatment starts, not after it ends.
Eight signs worth a consultation
Women often normalise these symptoms for years. A single examination and scan usually settle the question either way.
- ①Bleeding after menopause — even once.
- ②Bleeding between periods.
- ③Bloating that persists beyond two weeks.
- ④Pelvic pain that does not settle.
- ⑤Unusual vaginal discharge.
- ⑥Pain during intercourse.
- ⑦A symptom cycling back month after month.
- ⑧Whatever a relative dismissed as “normal for our family” — get it examined anyway.
Conditions this department treats
◆Ovarian Cancer
Staging and optimal cytoreduction — upfront or after interval chemotherapy.
◆Uterine / Endometrial Cancer
Staging surgery with sentinel-node mapping.
◆Cervical Cancer
Radical hysterectomy (Wertheim’s) with nodal assessment.
◆Vulvar Cancer
Localised resection with sentinel-node sampling.
◆Gestational Trophoblastic Disease
Managed on chemotherapy-first protocols with oncology teams.
◆Fertility Preservation
Selected early disease operated to keep options open.
Operations performed here
- ◆Staging laparoscopy / laparotomyThe true extent established before any treatment plan is locked.
- ◆Optimal cytoreduction for ovarian cancerDebulking pursued to visible-clear standards.
- ◆Radical hysterectomy (Wertheim’s)Complete removal with systematic nodal assessment.
- ◆Pelvic & para-aortic lymphadenectomyNodal basins assessed methodically.
- ◆Sentinel-node techniqueEndometrial and vulvar staging with minimal footprint.
- ◆Fertility-preserving optionsEarly disease, strict criteria, honest counselling.
From first visit to full recovery
- 10:00
First consultation
Symptoms heard without hurry; examination arranged without delay.
- 08:12
Staging workup
Imaging, markers and biopsy routes chosen to protect fertility options where relevant.
- 13:26
The plan together
Scope of surgery, menopause management and family-planning implications laid open.
- 09:15
Surgery
Staging or cytoreduction executed to standard, alongside gynae-oncology colleagues.
- 06:04
Day-one rounds
Mobility, drains and histopathology timelines tracked daily.
- 17:40
Home & surveillance
Hormone guidance, adjuvant therapy timed, follow-up rhythm set.
Families usually ask…
Overwhelmingly no — most cysts are functional and resolve on their own. Ultrasound features decide who needs surgery and who simply needs a repeat scan.
For selected early disease, yes — fertility-preserving surgery with strict follow-up is a real pathway. The criteria are strict because safety comes first, and eligibility is assessed honestly case by case.
Periods end and pregnancy becomes impossible; hormone effects depend on whether the ovaries remain. Quality of life usually improves once the disease is gone — expectations are discussed beforehand, not discovered afterwards.
Nearly all cervical cancers follow persistent HPV infection — which means vaccination, screening and early treatment of precancerous change interrupt that chain effectively.
Disease-specific: epithelial ovarian cancer usually requires it; early endometrial cancer often does not. The multidisciplinary board tailors the decision to final pathology.